BARCONA Trial: A Randomized Trial of Bardoxolone Methyl in Patients Infected with SARS-Corona Virus-2 (COVID-19)
Are you eligible to participate in this study?
You may be eligible for this study if you meet the following criteria:
-
Conditions: Covid-19
-
Age: Between 18 - 100 Years
-
Gender: Male or Female
-
Other Inclusion Criteria:
- Laboratory-confirmed COVID-19 infection as determined by polymerase chain reaction (PCR)
- Hospitalized patients who meet one of the following conditions:
- Radiographic infiltrates by imaging (chest x-ray, CT scan, etc.); OR
- At rest, blood oxygen saturation = 94%; OR
- Require supplemental oxygen; OR
- Requiring non-invasive ventilation; OR
- Requiring invasive mechanical ventilation for up to 2 days.
- Participant or legally authorized representative is willing to give informed consent
You may not be eligible for this study if the following are true:
-
- Intubated and on invasive mechanical ventilation for three or more days at the time of randomization
- Known left ventricular ejection fraction (LVEF) <40% or prior hospitalization for heart failure
- Cardiac arrest
- Shock
- Uncontrolled bacterial, fungal, or non-COVID viral infection
- eGFR <30 ml/min/1.73 m2 or requiring dialysis
- ALT or AST > 5X ULN
- History of cirrhosis, chronic active hepatitis or severe hepatic disease
- Pregnant or lactating women
- Enrolled in other trial of unapproved therapies, unless approved by trial Principal Investigator. In general, co-enrollment will be permitted unless there are safety concerns, mechanistic incompatibility or inability to adjudicate serious adverse events and will be decided on a case by case basis.
- If in the opinion of the clinical team, progression to death is imminent and inevitable within the next 24 hours, irrespective of the provision of treatments
If you are registered as a volunteer, please login to the dashboard to send referrals.